Merrill Lynch, Citi Hit In Class Action Over Cancer Co. IPO
Merrill Lynch, Citigroup and others involved with a West Coast cancer-treatment company's $240 million initial public offering last year allegedly overstated its financial prospects, which led to a massive drop in...To view the full article, register now.
Already a subscriber? Click here to view full article